JESSICA L HAMPTON
Allopathic & Osteopathic Physicians|Family Medicine TOPEKA, KS NPI 1528554144
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine KS ABBVIE INC. All categories
General Payments — all program years on this page
$3,651.96
- Category: General Payments
- Program years: PY2021–2024
- Record count: 198
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,298.12 across 68 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,298.12 | 68 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $225.50 | 17 |
| Axsome Therapeutics, Inc. | $214.94 | 3 |
| Novo Nordisk AS | $166.94 | 7 |
| Lilly USA, LLC | $153.34 | 11 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $91.12 | 6 |
| PFIZER INC. | $63.07 | 4 |
| Amgen Inc. | $59.47 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $49.69 | 2 |
| GlaxoSmithKline, LLC. | $42.78 | 3 |
| DEXCOM, INC. | $37.31 | 2 |
| CSL Behring | $30.64 | 1 |
| Saluda Medical Americas, Inc. | $28.83 | 1 |
| Otsuka America Pharmaceutical, Inc. | $23.55 | 1 |
| Acerta Pharma LLC | $22.34 | 1 |
| Abbott Laboratories | $22.03 | 1 |
| Merck Sharp & Dohme Corporation | $19.95 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.88 | 1 |
| Ascensia Diabetes Care US Inc. | $15.48 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.26 | 1 |
By program year
Records — PY2024 (68)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.